| No | 1 | Date of announcement | 2021/12/16 | Time of announcement | 17:19:51 |
|---|---|---|---|---|---|
| Subject | Oneness Biotech Co., LTD. receives "Prior Authorisation for Import of Traditional Medicines" from Macau on Fespixon cream (Research code: ON101) | ||||
| To which item it meets | paragraph 53 | Date of events | 2021/12/16 | ||
| Statement | |||||
|
1.Date of occurrence of the event:2021/12/16 2.Company name:ONENESS BIOTECH CO., LTD. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office 4.Reciprocal shareholding ratios:NA 5.Cause of occurrence:The Company has been informed by Authorized Agent that Macau issued ”Prior Authorisation for Import of Traditional Medicines” on Fespixon cream (Research code: ON101). 6.Countermeasures:None 7.Any other matters that need to be specified: (1)Fespixon cream can be exported to Macau after receiving ”Prior Authorisation for Import of Traditional Medicines” from Macau Health Bureau. (2)The exclusive commercialization right of Fespixon cream (Research code: ON101), a new drug for diabetic foot ulcer, for mainland China, Hong Kong and Macau has been licensed to Microbio (Shanghai) Co., Ltd. |
|||||
